NANOG and cancer: Cancer cell proliferation and capacity for transformation were impaired in the CD133 stable knockdown cell lines, which were accompanied by the suppression of stemness genes including NANOG, OCT4, SOX2, and c-MYC, suggesting that CD133 expression is required for tumor tissue growth and survival.